Aea Salicylic Acid Market Outlook - 2021–2030

The AEA salicylic acid market was valued at $274.5 million in 2020, and is projected to reach $553.8 million by 2030, growing at a CAGR of 7.3% from 2020 to 2030. Salicylic acid is a lipophilic monohydroxybenzoic acid, a type of phenolic acid, and a beta hydroxy acid, having molecular formula C₇H₆O₃. In terms of physical properties, it is odorless and colorless crystalline organic acid. Salicylic acid acts as intermediate in pharmaceutical and personal care industry.  

[COVIDIMPACTSTATEMENT]

The factor contributing toward the growth of the AEA salicylic acid market is increase in spending on cosmetics and personal care goods in developed countries. In addition, surge in demand for packaged food & beverages drives the market growth for salicylic acid. This is majorly attributed to the fact that the use of salicylic acid in the food & beverage industry is increasing, as it helps to prevent spoilage and fermentation of packaged food products.

Get more information on this report : Request Sample Pages

However, the availability of alternatives hinders the AEA salicylic acid market growth. In addition, implementation of stringent regulations, especially for skin and hair products, is one of the challenging factors for the market growth. On the contrary, expansion of the pharmaceutical industry in Africa is expected to offer lucrative opportunities for the industrial participants. Africa is one of the major importers of pharmaceutical products. Owing to its dependence on imports for most medicines, antibiotics, and other health products, Africa's vulnerability has been underlined by the COVID-19 pandemic. According to the United Nations Economic Commission for Africa (UNECA), Africa imports around 94% of its pharmaceutical and medicinal needs from outside the continent, at a cost of $16 billion per year. These factors provide high growth opportunity for pharmaceutical companies in the region to manufacture pharmaceutical products, which, in turn, is likely to foster the growth of the salicylic acid market.

The AEA salicylic acid market is segmented into application and region. Depending on application, the market is segregated into pharmaceutical, skin care, haircare, and food preservatives & others. Region wise, the AEA salicylic acid market share is analyzed across North America, Latin America, Europe, and Africa. 

The AEA salicylic acid market analysis covers in-depth information of the major industry participants. Some of the major players in the market are Alfa Aesar, Avonchem Limited, J.M. Loveridge Limited, Novacyl, Midas Pharma GmbH, Wego Chemical Group, Solvay Merck KGaA, and Reagents. Other players in the AEA salicylic acid market are Thermo Fisher Scientific, Alta Laboratories, and others.

[APPLICATIONGRAPH]

Get more information on this report : Request Sample Pages

By application, the pharmaceutical segment garnered highest market share in 2020 in terms of volume, garnering 60.1%. This is attributed to the fact that salicylic acid is used in pharmaceuticals due to its anti-inflammatory properties. Moreover, it is a key ingredient in the manufacturing of aspirin; it reacts with acetic acid to produce aspirin. Aspirin is an anti-inflammatory drug that is widely used as a painkiller and to treat fever, cold, and cough. In addition, it is one of the largest selling pharmaceutical drugs across the globe, and its consumption is on rise, as it offers superior pain-relieving action.  

Region wise, Latin America is expected to grow at a CAGR of 7.7%, in terms of revenue, during the forecast period. This is attributed to the presence of economies such as Brazil, Argentina, and Chile, which have rapidly growing consumer base. However, Africa is expected to grow at a CAGR of 7.6% in terms of revenue during the forecast period, owing to scarcity of medications in various nations, which drives the expansion of the pharmaceutical market. Furthermore, development of the fashion industry is likely to escalate the demand for skin care products, which is expected to fuel the demand for salicylic acid. In addition, rapid expansion of cities led to increase in salons, which led to rise in demand for salicylic acid-based products, thus augmenting the market growth.

[REGIONGRAPH]

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

• The report outlines the current AEA salicylic acid market trends and future scenario of the market from 2021 to 2030 to understand the prevailing opportunities and potential investment pockets.
• The AEA salicylic acid market size is provided in terms of volume and revenue.
• The report provides an in-depth analysis of the market along with the current and future AEA salicylic acid market trends.
• This report highlights the key drivers, opportunities, and restraints of the market along with impact analysis during the forecast period.
• The report further covers the impact of governmental regulations on the AEA salicylic acid market.
• The Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
• The study provides a comprehensive analysis of the factors that drive and restrain the AEA salicylic acid market growth.

Impact Of Covid-19 On The Aea Salicylic Acid Market

• The COVID-19 outbreak has affected the demand as well as manufacturing of salicylic acid.
• The global health crisis affected the chemical industry supply chain to a major extent, which led to a major impact on raw material procurement.
• As per the companies operating in the market, there are numerous uncertainties about the COVID-19 pandemic, comprising the scope of scientific and health problems, the expected period of the pandemic, and the political & economic disturbance it might cause.  
• The packaged food industry witnessed increased sales and profit. Consumers were increasing inventories as much as possible in March 2020, i.e., the initial phase of pandemic. This increased demand for salicylic acid from the food & beverage industry.
• The cosmetics industry witnessed decrease in product demand in the first quarter of 2020, owing to COVID-19 outbreak. In addition, store closures have affected the demand for cosmetics products. This has consequently decreased the demand for cosmetics raw materials such as salicylic acid. On the contrary, the pandemic had a positive impact on the overall market, owing to increase in online sales of cosmetic products are attributable to closure of saloons and beauty parlors. 

 Key Market Segments

• By APPLICATION
  • Pharmaceutical
  • Skin care
  • Haircare
  • Food preservative & others
• By Region
  • North America
    • U.S.
    • Canada
    • Mexico
  • Latin America
    • Brazil
    • Argentina
    • Chile
    • Rest of Latin America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Africa
    • Algeria
    • Egypt
    • Morocco
    • Rest of Africa

 
Key Market Players

• J.M. LOVERIDGE LTD.
• MERCK KGAA
• NOVACYL
• LARACHEM INC
• WEGO CHEMICAL GROUP
• AVONCHEM LIMITED
• MIDAS PHARMA GmbH
• REAGENTS
• SOLVAY
• ALFA AESAR

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research

1.5.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Surge in demand from preserved food & beverage industry
3.4.1.2.Increase in demand for personal care products

3.4.2.Restraint

3.4.2.1.Consumer awareness about harmful effects

3.4.3.Opportunities

3.4.3.1.High adoption of salicylic acid in pharmaceuticals and cosmetics
3.4.3.2.Rise in demand for aspirin drug

3.5.Value chain analysis
3.6.Patent analysis

3.6.1.Patent analysis by country

3.7.Value chain players
3.8.Pricing analysis
3.9.Salicylic acid derivative outlook (salicylates)

3.9.1.U.S.
3.9.2.Canada
3.9.3.Germany
3.9.4.UK

3.10.Salicylic acid derivatives
3.11.Impact of COVID-19 outbreak on the salicylic acid market

CHAPTER 4:AEA SALICYLIC ACID MARKET, BY APPLICATION

4.1.Overview

4.1.1.Market size and forecast, by region

4.2.Pharmaceutical

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Skin care

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Haircare

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Food preservative & others

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

CHAPTER 5:AEA SALICYLIC ACID MARKET, BY REGION

5.1.Overview

5.1.1.Market size and forecast, by region

5.2.North America

5.2.1.Key market trends, growth factors, and opportunity
5.2.2.Market Size and Forecast
5.2.3.Market size and forecast, by country

5.2.3.1.U.S.

5.2.3.1.1.Market size and forecast, by application

5.2.3.2.Canada

5.2.3.2.1.Market size and forecast, by application

5.2.3.3.Mexico

5.2.3.3.1.Market size and forecast, by application

5.3.Latin America

5.3.1.Key market trends, growth factors, and opportunity
5.3.2.Market Size and Forecast
5.3.3.Market size and forecast, by country

5.3.3.1.Brazil

5.3.3.1.1.Market size and forecast, by application

5.3.3.2.Argentina

5.3.3.2.1.Market size and forecast, by application

5.3.3.3.Chile

5.3.3.3.1.Market size and forecast, by application

5.3.3.4.Rest of Latin America

5.3.3.4.1.Market size and forecast, by application

5.4.Europe

5.4.1.Key market trends, growth factors, and opportunity
5.4.2.Market Size and Forecast
5.4.3.Market size and forecast, by country

5.4.3.1.France

5.4.3.1.1.Market size and forecast, by application

5.4.3.2.Germany

5.4.3.2.1.Market size and forecast, by application

5.4.3.3.Italy

5.4.3.3.1.Market size and forecast, by application

5.4.3.4.Spain

5.4.3.4.1.Market size and forecast, by application

5.4.3.5.UK

5.4.3.5.1.Market size and forecast, by application

5.4.3.6.Rest of Europe

5.4.3.6.1.Market size and forecast, by application

5.5.Africa

5.5.1.Key market trends, growth factors, and opportunity
5.5.2.Market Size and Forecast
5.5.3.Market size and forecast, by country

5.5.3.1.Algeria

5.5.3.1.1.Market size and forecast, by application

5.5.3.2.Egypt

5.5.3.2.1.Market size and forecast, by application

5.5.3.3.Morocco

5.5.3.3.1.Market size and forecast, by application

5.5.3.4.Rest of Africa

5.5.3.4.1.Market size and forecast, by application

CHAPTER 6:COMPETITIVE LANDSCAPE

6.1.Introduction

6.1.1.Market player positioning

6.2.Competitive heatmap
6.3.Key developments

6.3.1.Business expansion
6.3.2.Expansions

CHAPTER 7:COMPANY PROFILES

7.1.ALFA AESAR

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio

7.2.AVONCHEM LIMITED

7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio

7.3.J.M. LOVERIDGE LTD.

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segment
7.3.4.Product portfolio

7.4.NOVACYL

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Key strategic moves and developments

7.5.MIDAS PHARMA GmbH

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio

7.6.WEGO CHEMICAL GROUP

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Product portfolio

7.7.LARACHEM INC.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Product portfolio

7.8.MERCK KGAA

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Research and development
7.8.6.Business performance

7.9.REAGENTS

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Product portfolio

7.10.SOLVAY

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Research and development
7.10.6.Business performance

LIST OF TABLES

TABLE 01.LIST OFVALUE CHAIN PLAYERS
TABLE 02.LIST OF SALICYLIC ACID DERIVATIVES
TABLE 03.AEA SALICYLIC ACID MARKET REVENUE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 04.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 05.AEA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 06.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION, 2020–2030 (TON)
TABLE 07.AEA SALICYLIC ACID MARKET FOR PHARMACEUTICAL, BY REGION,2020–2030 ($MILLION)
TABLE 08.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 (TON)
TABLE 09.AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY REGION,2020–2030 ($MILLION)
TABLE 10.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 (TON)
TABLE 11.AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY REGION,2020–2030 ($MILLION)
TABLE 12.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 (TON)
TABLE 13.SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY REGION, 2020–2030 ($MILLION)
TABLE 14.AEA SALICYLIC ACID MARKET REVENUE, BY REGION, 2020-2030 ($MILLION)
TABLE 15.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 (TON)
TABLE 16.AEA SALICYLIC ACID MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 18.NORTH AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 20.NORTH AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 21.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 22.U.S. SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 23.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 24.CANADA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 26.MEXICO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 27.LATIN AMERICASALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 28.LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 29.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 30.LATIN AMERICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 31.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 32.BRAZIL SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 33.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 34.ARGENTINA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 36.CHILE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 37.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 38.REST OF LATIN AMERICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 39.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 40.EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 42.EUROPE SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 43.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 44.FRANCE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 45.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 46.GERMANY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 48.ITALY SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 49.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 50.SPAIN SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 51.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 52.UK SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 54.REST OF EUROPE SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 55.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 56.AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)
TABLE 58.AFRICA SALICYLIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 59.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 60.ALGERIA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 61.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 62.EGYPT SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 64.MOROCCO SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 65.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)
TABLE 66.REST OF AFRICA SALICYLIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 67.KEY EXPANSIONS
TABLE 68.ALFA: COMPANY SNAPSHOT
TABLE 69.ALFA: OPERATING SEGMENTS
TABLE 70.ALFA: PRODUCT PORTFOLIO
TABLE 71.AVONCHEM: COMPANY SNAPSHOT
TABLE 72.AVONCHEM: OPERATING SEGMENTS
TABLE 73.AVONCHEM: PRODUCT PORTFOLIO
TABLE 74.J.M. LOVERIDGE: COMPANY SNAPSHOT
TABLE 75.J.M. LOVERIDGE: OPERATING SEGMENT
TABLE 76.J.M. LOVERDIGE: PRODUCT PORTFOLIO
TABLE 77.NOVACYL: COMPANY SNAPSHOT
TABLE 78.NOVACYL: OPERATING SEGMENTS
TABLE 79.NOVACYL: PRODUCT PORTFOLIO
TABLE 80.NOVACYL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 81.MIDAS PHARMA: COMPANY SNAPSHOT
TABLE 82.MIDAS PHARMA: OPERATING SEGMENTS
TABLE 83.MIDAS PHARMA: PRODUCT PORTFOLIO
TABLE 84.WEGO: COMPANY SNAPSHOT
TABLE 85.WEGO: PRODUCT PORTFOLIO
TABLE 86.LARACHEM INC.: COMPANY SNAPSHOT
TABLE 87.LARACHEM INC.: PRODUCT PORTFOLIO
TABLE 88.MERCK: COMPANY SNAPSHOT
TABLE 89.MERCK: OPERATING SEGMENTS
TABLE 90.MERCK: PRODUCT PORTFOLIO
TABLE 91.MERCK: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 92.MERCK: NET SALES, 2018–2020 ($MILLION)
TABLE 93.REAGENTS: COMPANY SNAPSHOT
TABLE 94.REAGENTS: PRODUCT PORTFOLIO
TABLE 95.SOLVAY: COMPANY SNAPSHOT
TABLE 96.SOLVAY: OPERATING SEGMENTS
TABLE 97.SOLVAY: PRODUCT PORTFOLIO
TABLE 98.SOLVAY: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 99.SOLVAY: NET SALES, 2018–2020 ($MILLION)

LIST OF FIGURES

FIGURE 01.AEA SALICYLIC ACID MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS, BY COUNTRY
FIGURE 03.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 04.HIGH BARGAINING POWER OF BUYERS
FIGURE 05.MODERATE THREAT OF NEW ENTRANTS
FIGURE 06.MODERATE THREAT OF SUBSTITUTES
FIGURE 07.MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 08.AEA SALICYLIC ACID MARKET DYNAMICS
FIGURE 09.PATENT ANALYSIS, BY COUNTRY
FIGURE 10.PATENT ANALYSIS, BY APPLICANT
FIGURE 11.PATENT ANALYSIS, BY INVENTOR
FIGURE 12.SALICYLIC ACID PRICING ANALYSIS, BY REGION, (2020-2030)
FIGURE 13.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 14.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 15.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 16.IMPORT AND EXPORT OF O-ACETYLSALICYLIC ACID, ITS SALTS AND ESTERS
FIGURE 17.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR PHARMACEEUTICAL, BY COUNTRY,  2020& 2030($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR SKIN CARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF AEA SALICYLIC ACID MARKET FOR HAIRCARE, BY COUNTRY, 2020& 2030($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF SALICYLIC ACID MARKET FOR FOOD PRESERVATIVE & OTHERS, BY COUNTRY,  2020& 2030($MILLION)
FIGURE 21.U.S. SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 22.CANADA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 23.MEXICO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 24.BRAZIL SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 25.ARGENTINA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 26.CHILE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 27.REST OF LATIN AMERICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 28.FRANCE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 29.GERMANY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 30.ITALY SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 31.SPAIN SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 32.UK SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 33.REST OF EUROPE SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 34.ALGERIA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 35.EGYPT SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 36.MOROCCO SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 37.REST OF AFRICA SALICYLIC ACID MARKET, 2020–2030 ($MILLION)
FIGURE 38.MARKET PLAYER POSITIONING
FIGURE 39.COMPETITIVE HEATMAP OF KEY PLAYERS
FIGURE 40.MERCK: R&D, 2018–2020 ($MILLION)
FIGURE 41.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.MERCK: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 44.SOLVAY: R&D, 2018–2020 ($MILLION)
FIGURE 45.SOLVAY: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.SOLVAY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.SOLVAY: REVENUE SHARE BY REGION, 2020 (%)